Hap Trading, LLC Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $400,162 - $706,697	-10,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $185,888 - $264,032	-3,200 Reduced 24.06%	10,100 $50,000
Q3 2021 Nov 10, 2021	BUY	$58.38 - $84.96 $776,454 - $1.13 Million	13,300 New	13,300 $90,000
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $613,500 - $904,700	-10,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $162,134 - $315,869	-3,700 Reduced 27.01%	10,000 $149,000
Q4 2019 Feb 11, 2020	SELL	$28.14 - $73.01 $3.85 Million - $9.99 Million	-136,800 Reduced 90.9%	13,700 $282,000
Q3 2019 Nov 12, 2019	SELL	$26.26 - $34.86 $13,130 - $17,430	-500 Reduced 0.33%	150,500 $683,000
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $1.79 Million - $2.96 Million	-102,700 Reduced 40.48%	151,000 $645,000
Q1 2019 May 10, 2019	BUY	$12.05 - $20.18 $3.06 Million - $5.12 Million	253,700 New	253,700 $372,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.